Vimarsana
Biggest News Aggregation in the World

Page 2 - Analysis From News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Analysis From. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Analysis From Today - Breaking & Trending Today

Fenofibrate improves heart failure outcomes in patients with type 2 diabetes: ACCORD Lipid trial - Vimarsana News

Fenofibrate improves heart failure outcomes in patients with type 2 diabetes: ACCORD Lipid trial

Porto, Portugal: Recent data from the ACCORD Lipid trial showed that fenofibrate reduces the composite of HF hospitalizations or cardiovascular mortality in type 2 diabetes (T2D) patients treated with...

Top-10 Female Influential Figures in Crypto Industry - Vimarsana News

Top-10 Female Influential Figures in Crypto Industry

A sizable proportion of women believe that financial freedom is critical to their well-being. However, when we look across the cryptocurrency industry, we see that women make up a small percentage of the crypto space. For example, CoinSwitch Kuber reports that women account for only 15% of their customer base. Why do women avoid cryptocurrency? There are numerous theories as to why the cryptocurrency is still dominated by men. Cryptocurrency is often viewed from two perspectives: technology and finance. Women are frequently neglected and underrepresented in technology and finance. Some people ...

Zogenix To Present New FINTEPLA® (fenfluramine) Data at AES - Vimarsana News

Zogenix To Present New FINTEPLA® (fenfluramine) Data at AES

Data add to the growing body of evidence supporting the efficacy and safety profile of FINTEPLA for the treatment of Dravet syndrome...

New Data At ESC Congress 2021 Shows Repatha® (evolocumab) Improves Features Of Plaque Stability In Patients With Acute Coronary Syndrome (ACS) - Vimarsana News

New Data At ESC Congress 2021 Shows Repatha® (evolocumab) Improves Features Of Plaque Stability In Patients With Acute Coronary Syndrome (ACS)

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced positive data from the HUYGENS Phase 3 study showing that Repatha® (evolocumab) in addition to optimized...

Schafe müssen die Alp Scheenenbüehlen nach Wolfsangriffen verlassen, «viele Meldungen von Luchsrissen» - Vimarsana News

Schafe müssen die Alp Scheenenbüehlen nach Wolfsangriffen verlassen, «viele Meldungen von Luchsrissen»

Die Vereinigung zum Schutz von Wild- und Nutztieren vor Grossraubtieren im Kanton Bern berichtet von rund 40 Schafen, die vorzeitig abgealpt werden. Neben Wolfs- gebe es auch viele Luchsrisse – auch den Luchsbestand gelte es daher dringend zu regulieren.